HUMA vs IBRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

HUMA

56.9
AI Score
VS
HUMA Wins

IBRX

38.7
AI Score

Investment Advisor Scores

HUMA

57score
Recommendation
HOLD

IBRX

39score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric HUMA IBRX Winner
Forward P/E 35.8423 123.4568 HUMA
PEG Ratio 0 0 Tie
Revenue Growth 34.9% 93.9% IBRX
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 56.9/100 38.7/100 HUMA
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY HUMA

Relative Price Performance (Last 90 Days)

HUMA 1M: -27.0% · 3M: -33.9% IBRX 1M: -3.7% · 3M: +17.0%

Current Technical Phase

HUMA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -13.9%), weak momentum, RSI 38

RSI (14): 38.0 · Price: $0.41

IBRX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 41.5 · Price: $8.31

Fundamentals Snapshot

Metric HUMA IBRX
Market Cap — —
Forward P/E -1.7 -113.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.3% 0.9%
Gross Margin -37.4% 1.0%
Operating Margin -66.5% -1.2%
EPS -0.51 -0.97
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, HUMA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.